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Abstract  
Solvents such as methanol, ethanol, ethyl acetate, hexane and chloroform with extracts of Chromolaena odorata were tested 
against clinical bacteria (Escherichia coli and Staphylococcus aureus) and phytopathogenic bacteria (Xanthomonas 
vesicatoria and Ralstonia solanacearum). Among treatments, maximum In vitro inhibition was scored in methanol extracts of 
C. odorata which offered inhibition zone of 8mm, 7mm, 5mm and 7mm against tested bacteria E. coli, S. aureus, X. 
vesicatoria and R. solanaccearum, respectively. Further, ethyl-acetate and hexane extracts of C. odorata on TLC produced 9 
spots with varied level of inhibition. Partially purified compound from TLC (band 2) showed maximum inhibition against tested 
bacteria. The promising anti-microbial compound from ethyl-acetate and hexane extracts (5:5) of C. odorata was further 
purified using column chromatography which recorded 11mm, 10mm, 9mm and 7mm against E. coli, S. aureus, X. 
vesicatoria and R. solanaccearum, respectively. The minimum inhibitory concentration (MIC) value for clinical bacteria was 
ranged between 0.35 to 4.0 mg/ml and 0.25 to 4.0 mg/ml for phytopathogenic bacteria. HPLC chromatogram showed only 
one peak, where the retention time was 21.775 min. Structure of the anti-microbial compound was determined by Fourier 
Transform Infrared Spectra (FTIR) and 2D nuclear magnetic resonance (NMR) and liquid chromatography mass spectra (LC-
MS). The structure of anti-microbial compound found to be phenolic groups. LC-MS spectrum of methanolic extract of C. 
odorata compound exhibiting intense peak at m/z 301.3109 and the molecular weight of the compound was probably m/z 
437.4129. 
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INTRODUCTION 
Chromolaena odorata (L.) R. king and Rabinson 1970 (formely: 
Eupatorium odoratum L.), is an herbaceous perennial belongs to the 
family Asteraceae (=Compositae), is a diffuse, scrambling shrub that 
is mainly a weed of plantation crops and pastures of southern Asia 
and western Africa [1]. It grows to a height of 3m in the open 
situation and upto 8m when assumed a scrambling habitat in the 
interior forests [2]. It is native to Mexico, the West Indies, and tropical 
South America; it was spread widely by early navigators. It is 
commonly called saim weed, triffid weed, christmas bush, bitter bush 
or jack in the bush. It is a weed competes with 13 major crops in 23 
countries [3]. 
C. odorata commonly known as Eupatorium, is an alien, 
obnoxious and aggressive weed. It grows in pastures, marginal lands, 
open areas, dry deciduous forests and interior shrub jungles, where 
it is highly competitive and does not let other flora grow. It is menace 
in plantations, agriculture and other ecosystems. It suppresses 
young plantations, agricultural crops and smothers vegetation as it 
possesses allelopathic potentialities and growth inhibitors [1, 2, 4]. 
Previous investigations of the leaves and stems of C. odorata 
revealed the presence of essential oils [5-7], steroids, triterpenes [8 
and 9], and flavonoids [10-16]. Flowers of this plant have been 
subjected to investigate for essential oils [17], fats [18] and alkaloids 
[19]. It has been reported to have antispasmodic, antiprotozoal, 
antitrypanosomal, antibacterial and antihypersensitive activities. It 
has also been reported to possess anti-inflammatory, astringent, 
diuretic and hepatotropic activities [20-23]. In the southern part of 
Nigeria, the leaves of C. odorata are used for wound dressing, skin 
infection and to stop bleeding. Some specific phenolic compounds 
have also been isolated from the plant [24]. The medicinal values of 
plants lie in their component phytochemicals such as alkaloids, 
tannins, flavonoids and other phenolic compounds, which produce a 
definite physiological action on the human body [25]. A systematic 
search for useful bioactivities from medicinal plants is now 
considered to be a rational approach in neutraceutical and drug 
research. In this unfolding scenario, it is necessary to develop ways 
of putting C. odorata to beneficial uses. The assessment of nutritive 
value of C. odorata showed that it has good potential for feeding 
livestock due to its high crude protein (CP), low fibre and low 
extractable phenolic contents.  
In India, numerous studies have been carried out to extract 
various plant materials for screening antimicrobial compounds but 
much attention has not been focused on C. odorata. Therefore, by 
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considering the possibility of having antimicrobial compounds in C. 
odorata, we planned this study to isolate and characterize the 
antimicrobial compound which has considerable agrochemical 
properties, environmentally safe, and economically feasible. 
MATERIALS AND METHODS 
Plant material 
Fresh leaves of C. odorata were collected from different 
locations of Mysore (12.18 N– 76.42 E, 770 m above sea level), 
Karnataka, India, during 2007-2008. The plant was identified 
taxonomically and authenticated at the Herbarium, in University of 
Mysore, Mysore. Fresh leaves were washed thoroughly 2-3 times 
with running tap water and then with sterile water followed by shade-
dried, powdered and used for extraction. 
Test microorganisms 
Human pathogenic bacteria such as Escherichia coli and 
Staphylococcus aureus were collected from JSS medical college 
Mysore, India. Plant pathogenic bacteria such as Xanthomonas 
vesicatoria and Ralstonia solanacearum collected from the culture 
collection of department of applied botany and biotechnology, 
University of Mysore, India. All the test bacterial species were 
maintained on nutrient agar media.  
Preparation of solvent extraction 
Twenty five gram of shade dried, powder of plant materials were 
filled separately in the thimble and extracted successively with 150 
ml of methanol using a Soxhlet extractor for 48 hours. All the extracts 
were concentrated using rotary flash evaporator. After complete 
evaporation of solvent, each of these solvent extract was weighed 
and preserved at 4oC in airtight bottles until further use. One gram of 
methanol solvent residue was dissolved in 10 ml of respective 
solvent were used as the test extracts for antimicrobial activity assay. 
Activity guided purification of anti-microbial compound  
Thin layer chromatography (TLC) plates were prepared by 
making slurry of 30 gm of silica gel-G with 60 ml of distilled water. 
Spreading was done manually over glass plates (20x20cm) and air 
dried. The plates were activated in an oven for 3h at 110 0C. 
Methanolic extracts of C. odorata (100 mg sample dissolved in 1 ml 
of respective solvent) were used for TLC spotting. Separation of the 
TLC spots was done using different solvent system individually and 
in combinations using ethyl acetate: hexane (5: 5) as mobile phase. 
Spots developed on TLC plates were observed under UV 
transilluminator. Spots were eluted separately and isolated fractions 
were tested for its inhibition against four different micro organisms as 
described above. Further, the fractions showing maximum inhibition 
were rechromatographed on TLC plates using the same mobile 
phase. This process of repeated chromatography on TLC was 
carried out until a single fluorescing spot was obtained (Fig. 2B). The 
inhibition of all four different bacteria to all the TLC fractions were 
compared with negative control as well as positive control 
(Chloromphenicol standard antibiotic disc) (30mcg/disc). 
The partial purified compound obtained from methanolic extract 
of C. odorata by TLC (Described in materials and methods) was 
loaded into silica gel (60-120 mesh), (SRL, Mumbai) column 
(3510mm) and successively eluted with a stepwise gradient of ethyl 
acetate: hexane (0, 10, 25, 50, 75 and 100%). Fractions were 
collected at 20-min intervals. 
Reverse phase high performance liquid chromatography (RP-
HPLC)  
The analytical HPLC system with Waters LC 600 pump and 996 
Photo diode array detectors, C18 column was used at room 
temperature. Gradient elution propiles such as ‘A’ Trifluro acetic acid 
(TFA) and ‘B’ was MeOH-H2O, 1:1. The flow rate was 0.5 ml/min. 
Absorbance was measured at A215 and A225 nm 20µl of fraction was 
injected for separation. Further, minimum inhibitory concentration 
was checked for TLC purified methanolic extract instead of crude 
extract of C. odorata. 
Fourier transform infrared spectra (FTIR) 
The infrared spectra were recorded on Shimadzu IR-470 model. 
The spectra were scanned in the 400 to 4000 cm–1 range. The 
spectra were obtained using paraffin oil technique. One hundred µl 
of paraffin oil with 1mg of sample was taken and the spectra were 
plotted as intensity versus wave number. 
Nuclear magnetic resonance (NMR)  
The 2D 1H NMR and 13C NMR spectra were recorded with 
Brucker AM-500, Switzerland, (500MHz) spectrophotometer with the 
solvent signal as internal reference and chemical shifts were given in 
ppm. The compound sample was dissolved (7 mg for 1H NMR and 3 
mg for 13C NMR) in 3 ml of CDCl3 and analysed by nuclear magnetic 
resonance (NMR). 
Liquid chromatography mass spectra (LCMS) 
LCMS analysis was carried out using API QSTAR pulsar 
Germany and data dependent acquisition, during which compound 
precursor ions were detected by scanning from m/z 50 to 2000 with 
column flow rate of 5µl/min solvent A consisted of 90% (water in 
0.1% Trifluro acetic acid) and solvent B consisted of 10% 
(acetonitrile in 0.1% Trifluro acetic acid) and 30 µl sample were 
injected onto the column. 
RESULTS 
On TLC plates, ethyl acetate : hexane (5:5 v/v) with crude 
extracts of C. odorata developed various spots upon elution and 
tested against four bacteria and varied level of bacterial inhibition 
was noticed (Fig.1 A-D). 
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Fig. 1. Effect of methanolic crude extract of Chromolaena odorata (L) on against Escherichia coli (A), Staphylococcus aureus (B), Xanthomonas vesicatoria (C) and Ralstonia 
solanacearum (D). 
 
Under UV ethyl acetate : hexane (5:5 v/v) yielded nine spots 
with variable fluorescing ability consisting Rf values of 0.21, 0.37, 
0.46, 0.59, 0.65, 0.71, 0.76, 0.85, 0.98 (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.TLC Fingerprinting of methanol crude extracts (A) and Purified Compound (B) on TLC of C. odorata. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Inhibition of tested bacteria with purified compund isolated from C. odorata against Escherichia coli (A), Staphylococcus aureus (B), Xanthomonas vesicatoria (C) and 
Ralstonia solanacearum (D). 
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Again the antagonistic activity was rechecked for two bands. 
Band one showed very good activity (Fig. 3 A-D) compared to band 
2. The minimum Inhibitory concentration of purified compound was 
checked against four different bacteria (as mentioned earlier.) 
Escherichia coli, staphylococcus aureus and Xanthomonas 
vesicatoria have very good inhibitory effect than and Ralstonia 
solanacearum (Table 1). 
 
Table 1. Minimum inhibitory concentration (MIC) of Methanolic extract of Chromolaena odorata Purified compound   
Concentration (%) E.coli S.aureus X.vesicatoria R.solanacearum 
10 1 3 1 1 
20 2 4 2 2 
30 3 4 3 2 
40 4 5 5 3 
60 5 6 6.5 4 
80 7 7 7.2 5 
100 8.5 7.5 8 6 
Chloromphenicol 12 12 15 16 
(E.coli = Escherichia coli, S.aureus = Staphylococcus aureus, X.vesicatoria = Xanthomonas  vesicatoria, R.solanacearum = 
Ralstonia solanacearum)  
 
HPLC analysis  
The elutents used in the RP-HPLC analysis of phenolics are 
mixtures of aqueous pH modifiers with a polar, water-soluble organic 
solvent : methanol (MeOH), Trifluro acetic acid (TFA). HPLC 
chromatogram showed only one peak, where the retention time was 
21.775 min and the percentage of concentration was 100% (Fig. 4).  
 
Detector A - 2 (225nm)   
Pk # Retention Time Area Area Percent 
1 21.775 32031050 100.00 
    
Totals  32031050 100.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. High Performance liquid chromatogram showing single peak 
 
 
Fourier transform infrared spectra (FTIR) 
The Infra- Red spectrum (Fig. 5) of the isolated compound 
exhibits following absorptions (Table 2). 
 
Table 2. IR Spectrum peak number, wave number and functional groups 
Peak No. Wave number Functional  Group* 
1 3423 cm-1 Intermolecular H bonded O-H stretch 
2 2956cm-1 Aromatic C-H stretch 
3 2924cm-1 C-H stretching due to methylene group 
4 2854cm-1 C-H stretching due to methylene group 
8 1644cm-1 Overtone or combination bands 
9 1462cm-1 C=C ring stretch 
10 1376cm-1 In plane O-H bending 
12 1154cm-1 C-O stretching vibrations in alcohol and phenol 
13 1076cm-1 C-O stretching vibrations in alcohol and phenol 
16 723cm-1 Out of plane aromatic C-H bending 
*The above results indicate the presence of phenolic groups. 
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Fig. 5. IR Spectrum of methanolic extract of Chromolaena odorata compound. 
 
Nuclear magnetic resonance (NMR) and Liquid chromatography 
mass spectra (LC-MS) 
1H NMR and 13C NMR (500 MHz) spectrum data shows the 
purified compound to be phenolic compound (Supplementary Fig. 1 
and 2). LC-MS spectrum of methanolic extract of Chromolaena 
odorata compound exhibiting intense peak at m/z 301.3109 and the 
molecular weight of the compound was probably m/z 437.4129 (Fig. 
6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. LC-MS spectrum of methanolic extract of Chromolaena odorata compound exhibiting intense peak at m/z 301.3109 and 437.4129 molecular mass of compound. 
 
DISCUSSION 
Separation of the active fraction on TLC showed that two bands 
exhibited the antibacterial activity in the crude methanolic extract of 
C. odorata. Further, detailed investigation of these two bands again 
confirmed the presence of inhibitory activity of the extract. Remaining 
seven bands indicated the loss of antibacterial activity suggesting 
synergistic activity of the extract. There is a possibility of synergism 
between the compounds in crude extract than in isolated 
constituents [26]. 
C. odorata is a prolific producer of novel phytochemicals [25]. In 
the search for active compounds from C. odorata, the majority of 
research has been performed on extracts of the leaves which 
inhibited the growth of clinical bacteria such as Escherichia coli, and 
Staphylococcus aureus. However, it has not been tested on 
phytopathogenic bacteria such as Ralstonia solanacearum and 
Xanthomonas vesicatoria. It is clear that leaf extract with methanolic 
solvent showed varied degree of inhibitory effect on both clinical and 
plant pathogens. This might be due to the solubility of active 
compounds particular to specific solvents. Various investigators have 
shown that the use of different solvent influences the ability of the 
bioactive molecule in demonstrating different degrees of 
antimicrobial effect [27, 28]. The phenolic compounds of natural 
origin have the positive property of being soluble in polar solvents. 
This leads to the possibility of using reversed phase HPLC (RP-
HPLC) in their analysis, sufficient retention being achieved by using 
acidic conditions in order to avoid the presence of ionized forms of 
the analytes. The purified compound from methanolic extract of C. 
odoratum (3mg ml-1) consistently showed good inhibitory effect on 
above mentioned bacteria. These results demonstrated that C. 
odoratum has the potential for inhibiting the growth of above 
mentioned bacteria at low concentrations, even though, FTIR 
spectral data of the purified C. odorata compound showed the 
presence of phenolic groups. However, from our studies we 
observed that the mass weight of our phenolic compound is m/z 
437.4129.  
The need for new, safe and more effective antibacterial is a 
major challenge to the pesticides industry, especially with the 
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increase in phytopathogenic strains resistant to bactericides and also 
fungicides apart from being hazardous to environment and human 
health. On this background, the biotechnological potential of C. 
odoratum in terms of production of phenolic compound inhibiting 
both clinical and phytopathogenic bacteria is noteworthy. Results 
obtained in the present investigation indicated that C. odoratum 
produced a stable phenolic compound with active antimicrobial 
activity. 
 Field existences of antibiotic resistant phytopathogenic 
bacteria are increasing in recent years. WHO banned many 
agriculturally important pesticides due to wide range of toxicity 
against non target organisms including humans which are known to 
cause pollution [29]. Some of the developing countries are still using 
these pesticides despite their harmful effects. Exploitation of 
naturally available chemicals from plants, which retards the 
reproduction of undesirable microorganism, would be a more realistic 
and ecologically sound method for plant protection and will have a 
prominent role in the development of future commercial pesticides 
[30, 31]. Many reports on antibacterial activity of plants extract 
against human pathogens and their pharmaceutical application are 
available [32-35], but not much has been done on the antibacterial 
activity of plants extract against plant pathogens [35]. This is mainly 
due to lack of information on the screening/evaluation of diverse 
plants for their antibacterial potential. Thus the present study reveals 
that C. odorata is a potential and promising plant. Therefore it should 
be successfully exploited for the management of the diseases 
caused by different plant pathogenic bacteria which are known to 
cause many diseases in wide variety of crops. 
In the present investigation, the antibacterial activities of 
extracts of C. odorata against phytopathogenic bacteria like R. 
solancearum and X. vesicatoria has been demonstrated for the first 
time. A further detailed study is required to know the mode of action 
of these active ingredients on bacterial cell. However, the present 
investigation forms a basis for further research in this connection. To 
date, LC/ (API) MS technique have been widely accepted for the 
analysis of phenols, flavonoids, including a wide variety of different 
RP-HPLC conditions. The most frequent application of LC/MS in the 
analysis of phenols and flavonoids is a full scan over the selected 
m/z range during the course of an HPLC run. Being a 
complementary detection method to DVD-UV/Vis, this provides a 
basis for the identification of compounds for resolving the problem of 
co-eluted peaks. 
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